Nanoparticle Mosaic Quadrivalent Flu Vaccine Phase 1 Clinical Trial Gets Underway Medical Countermeasures June 1, 2021 …
Soligenix’s Innate Defense Regulator Selected for NIH Commercialization Transition Funding Contracts + Grants September 20, 2018 …
NIH Clinical Center Seeks Decontamination Services for Drug-Resistant Bacteria Antimicrobial Resistance July 12, 2018 …
RFI – National Gene Vector Biorepository and Coordinating Center Contracts + Grants January 23, 2017 …
NIH Awards 19M for Development of Nerve Agent Medical Countermeasures Contracts + Grants December 6, 2016 …
RFI – Supporting Development of Therapeutics for Rare and Neglected Diseases Contracts + Grants November 29, 2016 …
NIH Seeks Modular Trailer for Manufacturing Critical Retroviral Vectors Contracts + Grants July 20, 2016 …
